Product Details

Sandostatin LAR

Octreotide
20 mg
Powder for Injectable Suspension
Vial + Diluent in Prefilled Syringe Kit

DIN/PIN/NPN

02239324

Manufacturer

Novartis Pharma Canada Inc.

Formulary Listing Date

2007-01-02

Unit Price

1706.5800

Amount MOH Pays

1706.5800

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

92:00:00 Unclassified Therapeutic Agents

Therapeutic Note

NO

ATC Code

H01CB02

Interchangeable Products

NO

LU Clinical Criteria

NO

Requirements

EAP Criteria

NO

Product Monograph